International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 655-661 , 1 July 2010

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

  • Paul W. Sperduto, M.D., M.P.P.

      Affiliations

    • Gamma Knife Center, University of Minnesota, Minneapolis, MN
    • Corresponding Author InformationReprint requests to: Paul Sperduto, M.D., M.P.P., Gamma Knife Center, University of Minnesota, 560 S. Maple St., Waconia, MN 55387. Tel: (952) 442-6000; Fax: (952) 442-7851
    • ,
  • Samuel T. Chao, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH
    • ,
  • Penny K. Sneed, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA
    • ,
  • Xianghua Luo, Ph.D.

      Affiliations

    • Division of Biostatistics, University of Minnesota, Minneapolis, MN
    • ,
  • John Suh, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH
    • ,
  • David Roberge, M.D.

      Affiliations

    • Department of Radiation Oncology, McGill University Health Center, Montreal, ON, Canada
    • ,
  • Amit Bhatt, M.D.

      Affiliations

    • Department of Human Oncology, University of Wisconsin at Madison, Madison, WI
    • ,
  • Ashley W. Jensen, M.D.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN
    • ,
  • Paul D. Brown, M.D.

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN
    • ,
  • Helen Shih, M.D.

      Affiliations

    • Massachusetts General Hospital, Harvard Medical School, Boston, MA
    • ,
  • John Kirkpatrick, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • ,
  • Amanda Schwer, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Colorado Health Science Center, Denver, CO
    • ,
  • Laurie E. Gaspar, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Colorado Health Science Center, Denver, CO
    • ,
  • John B. Fiveash, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Alabama Medical Center at Birmingham, Birmingham, AL
    • ,
  • Veronica Chiang, M.D.

      Affiliations

    • Department of Neurosurgery, Yale University School of Medicine, New Haven, CT
    • ,
  • Jonathan Knisely, M.D.

      Affiliations

    • Department of Radiation Oncolog, Yale University School of Medicine, New Haven, CT
    • ,
  • Christina Maria Sperduto

      Affiliations

    • Minneapolis Radiation Oncology, Minneapolis, MN
    • ,
  • Minesh Mehta, M.D.

      Affiliations

    • Department of Human Oncology, University of Wisconsin at Madison, Madison, WI

Received 16 June 2009 ,Revised 7 August 2009 ,Accepted 10 August 2009.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58:71–96
  2. Zimm S, Wampler GL, Stablein D, et al. Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer. 1981;48:384–394
  3. Posner JB. Neurologic complications of cancer. Philadelphia: FA Davies; 1995;
  4. Sperduto P, Hall W. The cost-effectiveness of alternative treatments for single brain metastases. In: Kondziolka D (ed): Radiosurgery 1995. Basel, Karger. 1996;1:180–187
  5. Mehta M, Noyes W, Craig B, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single brain metastases. Int J Radiat Oncol Biol Phys. 1997;39:445–454
  6. Rutigliano MJ, Lunsford LD, Kondziolka D, et al. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995;37:445–455
  7. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751
  8. Gaspar L, Scott C, Murray K, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001–1006
  9. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–1672
  10. Sperduto P, Berkey B, Gaspar LE, et al. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70:510–514
  11. Sperduto CM, Watanabe Y, Mullan J, et al. A validation study of a new prognostic index for patients with brain metastases: The graded prognostic assessment. J Neurosurg. 2008;109:87–89
  12. Sperduto P, Sneed P, Bhatt A, et al. A multi-institutional validation study of a new prognostic index (graded prognostic assessment, GPA) for patients with brain metastases. American Society for Therapeutic Radiology Oncology. [Abstract 111] Int J Radiat Oncol Biol Phys. 2008;72:S51
  13. Golden DW, Lamborn KR, McDermott MW, et al. Prognostic factors and grading systems for overall survival in patients with radiosurgery for brain metastases: Variation by primary site. J Neurosurg. 2008;109:77–86
  14. Komarnicky LT, Phillips TL, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG 79-16). Int J Radiat Oncol Biol Phys. 1991;20:53–58
  15. Sause WT, Scott C, Kirsch R, et al. Phase I/II trial of accelerated fractionation in brain metastases, RTOG 85-28. Int J Radiat Oncol Biol Phys. 1993;26:653–657
  16. Phillips TL, Scott CB, Leibel S, et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine to radiotherapy alone for brain metastases: Report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys. 1995;33:339–348
  17. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastasis: A report of RTOG 9104. Int J Radiat Oncol Biol Phys. 1997;39:571–574
  18. Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: A review. J Clin Oncol. 1988;6:543–551
  19. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500
  20. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA. 1998;280:1485–1489
  21. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53:519–526
  22. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases, a randomized controlled trial. JAMA. 2006;295:2483–2491
  23. Patchell RA, Regine WF, Loeffler JS, et al. Letter to editor regarding Aoyama H, Shirato H Tago M, et al. Multi-institutional prospective randomized comparison of stereotactic radiosurgery plus upfront whole brain radiation therapy versus stereotactic radiosurgery alone for the treatment of solitary and multiple brain metastases. JAMA. 2006;296:2089–2090
  24. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789–796
  25. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol. 2004;22:157–165
  26. Regine WF, Scott C, Murray K, et al. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys. 2001;51:711–717
  27. Aoyama H, Tago M, Koto N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007;68:1388–1395
  28. Chang EL, Wefel JS, Maor MH, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007;60:277–283
  29. Li J, Bentzen SM, Renschler M, et al. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007;25:1260–1266
  30. Brown PD, Asher AL, Farace E. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. Int J Radiat Oncol Biol Phys. 2008;70:1305–1309
  31. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: Current knowledge and future directions. Int J Radiat Oncol Biol Phys. 1995;31:983–998

 Conflict of interest: none.

PII: S0360-3016(09)02972-1

doi: 10.1016/j.ijrobp.2009.08.025

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 655-661 , 1 July 2010

Article Tools